Claim Money in a New $4.5M Class Action Settlement for Robitussin Products. This lawsuit alleges that certain Robitussin products containing dextromethorphan (or “DXM”) were deceptively marketed, advertised, labeled, and sold as “Non-Drowsy”.
- If you purchased select Robitussin products between February 16, 2016, and January 21, 2025.
- Class members can receive anywhere from $1.50 to $4.75 per claim, depending on how many claims are submitted.
- The claim date is fast approaching! Go hee to submit your claims online by 5/12/25 date.
